乳腺癌仍然是美国女性最常见的恶性肿瘤。减少这种癌症的负担需要识别高风险人群和个性化的风险管理。由于冠状动脉疾病仍然是妇女死亡的主要原因，任何减少乳腺癌风险的干预都必须权衡与影响心血管风险降低的共病和干预措施的影响。对于高风险患者中选择的女性，预防性药物可以大大降低风险，但使用率极低。妇女健康临床医生有能力评估风险，促进乳腺癌风险降低，并管理整体健康。 Copyright © 2022 The Cleveland Clinic Foundation. All Rights Reserved.

Breast cancer remains the most common female malignancy in the United States. Reducing this cancer burden involves identification of high-risk individuals and personalized risk management. Because coronary artery disease remains the primary cause of death for women, any intervention to reduce breast cancer risk must be weighed against comorbidities and interventions affecting cardiovascular risk reduction. For select women at increased risk for breast cancer, preventive medication can greatly decrease risk and is vastly underutilized. Women's health clinicians are poised to evaluate risk, promote breast cancer risk reduction, and manage overall health.Copyright © 2022 The Cleveland Clinic Foundation. All Rights Reserved.